182 related articles for article (PubMed ID: 20620978)
1. Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches.
Morrison VA
Best Pract Res Clin Haematol; 2010 Mar; 23(1):145-53. PubMed ID: 20620978
[TBL] [Abstract][Full Text] [Related]
2. Infectious complications of chronic lymphocytic leukemia.
Wadhwa PD; Morrison VA
Semin Oncol; 2006 Apr; 33(2):240-9. PubMed ID: 16616071
[TBL] [Abstract][Full Text] [Related]
3. The infectious complications of chronic lymphocytic leukemia.
Morrison VA
Semin Oncol; 1998 Feb; 25(1):98-106. PubMed ID: 9482531
[TBL] [Abstract][Full Text] [Related]
4. Update on prophylaxis and therapy of infection in patients with chronic lymphocytic leukemia.
Morrison VA
Expert Rev Anticancer Ther; 2001 Jun; 1(1):84-90. PubMed ID: 12113137
[TBL] [Abstract][Full Text] [Related]
5. Infectious complications in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approaches to prophylaxis.
Morrison VA
Clin Lymphoma Myeloma; 2009 Oct; 9(5):365-70. PubMed ID: 19858055
[TBL] [Abstract][Full Text] [Related]
6. Infection and immunity in chronic lymphocytic leukemia.
Tsiodras S; Samonis G; Keating MJ; Kontoyiannis DP
Mayo Clin Proc; 2000 Oct; 75(10):1039-54. PubMed ID: 11040852
[TBL] [Abstract][Full Text] [Related]
7. Management of infectious complications in patients with chronic lymphocytic leukemia.
Morrison VA
Hematology Am Soc Hematol Educ Program; 2007; ():332-8. PubMed ID: 18024648
[TBL] [Abstract][Full Text] [Related]
8. Infectious complications in chronic lymphocytic leukaemia.
Morra E; Nosari A; Montillo M
Hematol Cell Ther; 1999 Aug; 41(4):145-51. PubMed ID: 10543369
[TBL] [Abstract][Full Text] [Related]
9. [Pathogenesis, prophylaxis and treatment of infections in patients with chronic lymphocytic leukemia].
Stelmach P; Robak T
Postepy Hig Med Dosw (Online); 2013 Jun; 67():560-8. PubMed ID: 23799400
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody therapy of chronic lymphocytic leukaemia.
Cheson BD
Best Pract Res Clin Haematol; 2010 Mar; 23(1):133-43. PubMed ID: 20620977
[TBL] [Abstract][Full Text] [Related]
11. Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma: implications for clinical trials in this patient population.
Perkins JG; Flynn JM; Howard RS; Byrd JC
Cancer; 2002 Apr; 94(7):2033-9. PubMed ID: 11932906
[TBL] [Abstract][Full Text] [Related]
12. Due to low infection rates no routine anti-infective prophylaxis is required in younger patients with chronic lymphocytic leukaemia during fludarabine-based first line therapy.
Eichhorst BF; Busch R; Schweighofer C; Wendtner CM; Emmerich B; Hallek M;
Br J Haematol; 2007 Jan; 136(1):63-72. PubMed ID: 17083342
[TBL] [Abstract][Full Text] [Related]
13. Rituximab in chronic lymphocytic leukemia.
Jaglowski SM; Byrd JC
Semin Hematol; 2010 Apr; 47(2):156-69. PubMed ID: 20350663
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies in chronic lymphocytic leukemia.
Ferrajoli A; Faderl S; Keating MJ
Expert Rev Anticancer Ther; 2006 Sep; 6(9):1231-8. PubMed ID: 17020457
[TBL] [Abstract][Full Text] [Related]
15. Pact with the devil: alemtuzumab therapy, immune suppression and infectious complications in chronic lymphocytic leukemia.
Antohe I; Dascalescu A; Burcoveanu C; Ghiorghiu D; Dascalu A; Danaila C
Rev Med Chir Soc Med Nat Iasi; 2014; 118(1):92-5. PubMed ID: 24741782
[TBL] [Abstract][Full Text] [Related]
16. Early and late infectious consequences of adding rituximab to fludarabine and cyclophosphamide in patients with indolent lymphoid malignancies.
Tam C; Seymour JF; Brown M; Campbell P; Scarlett J; Underhill C; Ritchie D; Bond R; Grigg AP
Haematologica; 2005 May; 90(5):700-2. PubMed ID: 15921393
[TBL] [Abstract][Full Text] [Related]
17. Nursing guidelines for managing infections in patients with chronic lymphocytic leukemia.
Moran M; Browning M; Buckby E
Clin J Oncol Nurs; 2007 Dec; 11(6):914-24. PubMed ID: 18063549
[TBL] [Abstract][Full Text] [Related]
18. A review of the infection pathogenesis and prophylaxis recommendations in patients with chronic lymphocytic leukemia.
Tadmor T; Welslau M; Hus I
Expert Rev Hematol; 2018 Jan; 11(1):57-70. PubMed ID: 29160119
[TBL] [Abstract][Full Text] [Related]
19. A review of supportive care and recommended preventive approaches for patients with chronic lymphocytic leukemia.
Randhawa JK; Ferrajoli A
Expert Rev Hematol; 2016 Mar; 9(3):235-44. PubMed ID: 26652692
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody therapy of chronic lymphocytic leukemia.
Mavromatis B; Cheson BD
J Clin Oncol; 2003 May; 21(9):1874-81. PubMed ID: 12721266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
